Idiopathic Intracranial Hypertension
Conditions
Brief summary
Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.
Detailed description
This study is a prospective cohort study. Investigators plan to include 50 patients in whom the IIH-diagnosis is suspected. Patients are referred from general practitioners, neurologists or ophthalmologists to the Danish Headache Center or admitted to the Neurology ward when the IIH diagnosis is suspected. As part of an established routine clinical work-up to establish the diagnosis of IIH, all patients will undergo (according to the Friedman criteria) the following examinations: A) 1. An interview (history taking) and clinical examination 2. Routine laboratory tests (blood tests) 3. Ophthalmological examination 4. Lumbar puncture with measurement of the ICP 5. Magnetic resonance imaging (MRI) of the brain Additionally the following investigations will be performed at baseline (before and after lumbar puncture): B) Transorbital sonography (TOS) C) Transcranial Doppler When the patient is seen at the clinic for their regular follow-up visits the same measurements will be done. A control group of healthy participants (NR=25) will be included in whom TOS (B) and TCD (C) will be performed in order to compare the values between the patient group (IIH) and control group. Controls will be included to match the patients according to BMI, age and gender. All ultrasound images- and films will be saved, and evaluated by a blinded investigator.
Interventions
DIAGNOSTIC_TESTTOS and TCD
TOS: Transorbital sonography TCD: Transcranial Doppler
Sponsors
Danish Headache Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Intervention model description
Single group, prospective cohort study with healthy controls.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
PATIENT GROUP (ARM 1): Inclusion Criteria: * Age 18-65 * Patients in whom the IIH diagnosis is suspected/or confirmed * The diagnosis of migraine with or without aura or tension-type headache is allowed as a comorbid headache type. * Participants must read and understand the Danish language, or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study
Exclusion criteria
* Pregnant or breastfeeding females * Patients who do not need a diagnostic lumbar puncture at the time of evaluation * Patients treated with acetazolamide, topiramate or furosemide for IIH or suspected IIH before inclusion in the study (baseline) * Any other primary or secondary headache diagnosis than migraine with or without aura or tension type headache as a comorbid disorder * Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases * Participants with secondary causes of raised intracranial pressure, or patients that have been treated for such (e.g. brain tumor, hydrocephalus, stroke or severe head injury) * Participants with known atherosclerotic disease or known heart disease CONTROL GROUP (ARM 2): Inclusion criteria: * Age 18-65 * Healthy persons who do not suffer from any form of primary headache except infrequent tension-type headache * Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between opening pressure and ONSD | 1 year | Optic nerve sheath diameter (ONSD) potential correlation with opening pressure. |
| Correlaton between opening pressure and ONSD/ETD ratio | 1 year | ONSD/ETD (external transverse diameter) ratio and potential correlation with opening pressure. |
| Comparison of ONSD in IIH and healthy controls | 1 year | Comparison of ONSD in patients with elevated ICP (IIH) and healthy controls, age- sex and BMI matched. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in the optic nerve (ODE) | 1 month | Changes in ODE (optic disc elevation) after 1 month |
| TCD (PI - pulsatility index) in patients with IIH | 2 years | Evaluation of pulsatility index for major intracranial arteries (PI) using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. |
| Optic disc elevation | 1 year | Optic disc elevation measured by ultrasound in IIH compared with healthy controls |
| TCD (RI - resistance index) in patients with IIH | 2 years | Evaluation of resistance index (RI) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. |
| Neuro-ophthalmological evaluation of papilledema versus ultrasound evaluation of the optic nerve | 2 years | Papilledema and the optic nerve is usually evaluated by neuro-ophthalmologists in patients with IIH. Investigators will compare this evaluation with the assessment made by TOS ultrasound. |
| TCD (MBFV - mean blood flow velocity) in patients with IIH | 2 years | Evaluation of mean blood flow velocity (MBFV) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. |
| ONSD diameter on MR c in patients with IIH | 1 year | ONSD and correlation with ONSD on orbital MRI. |
| Changes in the optic nerve (ONSD) | 1 month | Changes in ONSD after 1 month |
Countries
Denmark
Outcome results
None listed